Hims & Hers Health, Inc. (HIMS) Announces Expansion To Canada
Hims & Hers Health, Inc. (NYSE:HIMS) is among the 13 Best Booming Stocks to Buy Now.
Hims & Hers Health Inc. (HIMS)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 0 | $0 | 0% | ||
| 2. | Royce & Associates Chuck Royce | 0 | $0 | 0% | |
| 3. | Magnetar Capital Alec Litowitz And Ross Laser | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | ||
| 5. | Hudson Bay Capital Management Sander Gerber | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $24.50 | 1,000 | $24,500.00 | 5,000 | 2024-11-14 | Filing | |
| $26.94 | 4,000 | $107,759.60 | 4,000 | 2024-11-12 | Filing | |
| $17.74 | 110,000 | $1,951,763.00 | 110,000 | 2024-05-21 | Filing | |
| $3.66 | 73,700 | $269,742.00 | 125,000 | 2022-06-14 | Filing | |
| $3.66 | 1,300 | $4,751.50 | 51,300 | 2022-06-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $47.82 | 2,572 | $122,993.04 | 158,165 | 2025-07-14 | Filing | |
| $47.70 | 11,581 | $552,418.33 | 54,084 | 2025-07-14 | Filing | |
| $46.67 | 11,581 | $540,498.01 | 58,078 | 2025-07-07 | Filing | |
| $50.50 | 2,572 | $129,886.00 | 160,737 | 2025-06-30 | Filing | |
| $47.25 | 23,107 | $1,091,766.47 | 63,222 | 2025-06-23 | Filing |
Institutional Investors' Holdings
News See All
Hims (HIMS) Jumps 8.6% as Firm Still Open to Work With Novo
Hims & Hers bounced back by 8.64 percent on Monday to close at $52.03 following announcements that it remains open to working with Novo Nordisk in the future despite the termination of its earlier partnership...
Hims & Hers (HIMS): A Bear Case Theory
We came across a bearish thesis on Hims & Hers on FJ Research's Substack. As of 3ʳᵈ July, Hims & Hers's share was trading at $47.98.
13 Best Booming Stocks to Buy Now
A day after posting a new record high, the S&P 500 closed 0.33% lower on Friday due to an escalation in the trade war, with President Trump announcing a 35% tariff on Canada and threatening to impose ...
Hims & Hers Health, Inc. (HIMS) Isn't Regarded As A Great Actor By Doctors, Says Jim Cramer
Hims & Hers Health, Inc. (NYSE:HIMS) is a well-known digital health platform that allows users to order medicines after securing prescriptions.
14 Stocks Jim Cramer Discussed As He Talked About Record Bitcoin Price
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer discussed the recent Bitcoin price jumps.
Hims & Hers Expands into Europe with ZAVA Acquisition
Hims & Hers Health Inc. (NYSE:HIMS) is one of the best NYSE stocks to buy for long term investment.
10 Best NYSE Stocks to Buy for Long Term Investment
On June 16, Stephanie Link, Hightower Advisors' chief investment strategist and portfolio manager, joined CNBC's ‘Squawk Box’ to discuss the latest market trends.
Hims & Hers (HIMS) Jumps 6.76% Anew as Investors Cheer Weight Loss Drug Fight
Hims & Hers extended its rally for the second day on Friday, adding 6.76 percent to close at $49.41 apiece after its chief executive’s reaffirmation that the company will continue to offer cheaper compounded...
Hims & Hers (HIMS) Rallies 11.76% as CEO Not Backing Down After Novo Nordisk Spat
Hims & Hers rebounded by 11.76 percent on Thursday to close at $46.28 apiece amid reaffirmations to continue offering cheaper compounded versions of GLP-1 weight-loss drugs, despite the cancellation of...
Billionaire Hedge Funds
